{
    "2018-03-26": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Merck, Eisai Get Japanese Nod for Lenvima Label Expansion",
                "features": {
                    "keywords": [
                        "Merck",
                        "Eisai",
                        "Japanese",
                        "Lenvima",
                        "label expansion"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "Novartis CEO on China Growth, Technology Usage and R&D",
                "features": {
                    "keywords": [
                        "Novartis",
                        "CEO",
                        "China",
                        "growth",
                        "technology",
                        "R&D"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-12",
                "original_text": "Novartis CEO Sees China Business Doubling Over Five Years",
                "features": {
                    "keywords": [
                        "Novartis",
                        "CEO",
                        "China",
                        "business",
                        "doubling"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-15",
                "original_text": "Novartis CEO Aims to Double China Sales on Faster Drug Approvals",
                "features": {
                    "keywords": [
                        "Novartis",
                        "CEO",
                        "China",
                        "sales",
                        "drug approvals"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-05",
                "original_text": "Exploring Xencor’s Revenue Trend",
                "features": {
                    "keywords": [
                        "Xencor",
                        "revenue",
                        "trend"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-10",
                "original_text": "Xencor’s Promising Research Pipeline",
                "features": {
                    "keywords": [
                        "Xencor",
                        "research",
                        "pipeline"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-06-01",
                "original_text": "Novartis Gets Positive CHMP Opinion on Biosimilar Remicade",
                "features": {
                    "keywords": [
                        "Novartis",
                        "CHMP",
                        "opinion",
                        "biosimilar",
                        "Remicade"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-06-15",
                "original_text": "AI. Telemedicine. Quantum. New Novartis Boss Says Tech Will Finally Change The Drug Biz",
                "features": {
                    "keywords": [
                        "AI",
                        "telemedicine",
                        "quantum",
                        "Novartis",
                        "tech",
                        "drug biz"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-07-05",
                "original_text": "Will Teva’s Fremanezumab Be Delayed due to Troubles at Celltrion?",
                "features": {
                    "keywords": [
                        "Teva",
                        "Fremanezumab",
                        "delayed",
                        "Celltrion"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-08-10",
                "original_text": "Incyte’s Collaborations and Developments in 2018",
                "features": {
                    "keywords": [
                        "Incyte",
                        "collaborations",
                        "developments",
                        "2018"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-15",
                "original_text": "The Swiss Stock Market Finished Lower After Late Pullback",
                "features": {
                    "keywords": [
                        "Swiss",
                        "stock market",
                        "lower",
                        "pullback"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-10-20",
                "original_text": "Incyte’s Jakafi in 2017",
                "features": {
                    "keywords": [
                        "Incyte",
                        "Jakafi",
                        "2017"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}